📊FDA Notice on Real Cost Campaign Outcomes Evaluation Study
Agency Information Collection Activities; Proposed Collection; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3
Summary
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the extension of the currently approved collection "The Real Cost Campaign Outcomes Evaluation Study: Cohort 3."
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
The regulatory text involves the FDA's proposed collection of information which includes public commentary on the "Real Cost Campaign Outcomes Evaluation Study." This indicates a compliance requirement for businesses related to tobacco products as they may need to adapt operations based on impacts from new research findings or campaigns stemming from this study.